Crinetics Pharmaceuticals Income Statement (2017-2025) | CRNX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.83M	0.64M	0.53M	0.44M	0.66M	0.55M	0.78M	0.37M		0.51M	0.32M	0.07M								3.13M	0.44M	0.46M	0.71M	2.68M	0.99M	0.35M		0.64M	0.40M			0.36M	1.03M	0.14M
Operating items
Research & Development	2.08M	2.52M	2.56M	4.72M	5.22M	6.89M	7.65M	7.25M	10.29M	11.82M	12.14M	13.86M	12.61M	13.70M	16.83M	17.58M		21.58M	20.49M	28.25M	32.99M	31.99M	36.99M	38.47M	40.64M	43.84M	45.58M	53.34M	58.34M	61.91M	66.57M	76.24M	80.30M	90.46M
Selling, General & Administrative	0.39M	0.49M	0.47M	1.25M	1.12M	1.73M	2.56M	3.16M	3.06M	3.91M	3.39M	3.99M	4.32M	4.75M	4.96M	5.33M		6.23M	5.60M	8.71M	10.49M	11.93M	11.27M	12.19M	13.34M	15.48M	17.08M	20.83M	24.84M	25.89M	28.18M	35.53M	49.84M	52.27M
Operating Expenses	2.48M	3.01M	3.03M	5.97M	6.34M	8.62M	10.21M	10.41M	13.35M	15.73M	15.54M	17.85M	16.93M	18.45M	21.79M	22.92M		27.81M	26.09M	36.96M	43.48M	43.91M	48.27M	50.66M	53.98M	59.32M	62.66M	74.17M	83.18M	87.80M	94.75M	111.77M	130.14M	142.73M
Operating Income	-2.61M	-2.37M	-2.50M	-5.53M	-5.68M	-8.07M	-9.43M	-10.04M	-13.35M	-15.23M	-15.21M	-17.78M	-16.93M	-18.45M	-21.79M	-22.92M		-27.81M	-26.09M	-33.83M	-43.05M	-43.45M	-47.56M	-47.98M	-52.99M	-58.98M	-62.66M	-73.53M	-82.78M	-87.80M	-94.75M	-111.41M	-129.11M	-142.59M
EBIT	-2.61M	-2.37M	-2.50M	-5.53M	-5.68M	-8.07M	-9.43M	-10.04M	-13.35M	-15.23M	-15.21M	-17.78M	-16.93M	-18.45M	-21.79M	-22.92M		-27.81M	-26.09M	-33.83M	-43.05M	-43.45M	-47.56M	-47.98M	-52.99M	-58.98M	-62.66M	-73.53M	-82.78M	-87.80M	-94.75M	-111.41M	-129.11M	-142.59M
Non-operating items
Non Operating Investment Income																										-1.00M
Interest & Investment Income	0.01M	0.01M	0.01M	0.06M	0.15M	0.53M	1.00M	1.01M	0.96M	0.83M	0.66M	0.56M	0.26M	0.12M	0.05M	0.03M		0.02M	0.02M	0.19M	0.72M	1.50M	1.90M	2.04M	2.11M	2.57M	6.72M	7.32M	8.74M	11.01M	14.37M	14.83M	13.46M	12.54M
Other Non Operating Income																														-0.04M				-0.05M
Non Operating Income	-0.00M	-0.01M	0.08M	0.06M	0.12M	0.48M	0.94M	1.03M	0.92M	0.80M	0.67M	0.42M	0.44M	0.13M	0.15M	0.02M		-0.07M	-0.06M	0.21M	0.67M	1.53M	2.56M	1.98M	2.02M	2.52M	6.76M	7.07M	8.73M	10.97M	14.15M	14.63M	13.47M	12.49M
Net income details
EBT	-2.60M	-2.37M	-2.50M	-5.46M	-5.53M	-7.54M	-8.43M	-9.03M	-12.38M	-14.39M	-14.56M	-17.23M	-16.67M	-18.33M	-21.74M	-22.89M		-27.78M	-26.07M	-33.63M	-42.33M	-41.95M	-45.65M	-45.94M	-50.89M	-56.41M	-55.94M	-66.21M	-74.04M	-76.83M	-80.38M	-96.57M	-115.66M	-130.09M
Profit After Tax	-1.65M	-2.38M	-2.52M	-5.46M	-5.57M	-7.59M	-8.49M	-9.02M	-12.43M	-14.43M	-14.55M	-17.36M	-16.49M	-18.32M	-21.64M	-22.90M		-27.85M	-26.09M	-34.63M	-42.38M	-41.92M	-44.99M	-45.99M	-50.98M	-57.46M	-60.10M	-66.93M	-74.06M	-76.83M	-80.59M	-96.77M	-115.64M	-130.09M
Equity Income																				-1.01M						-1.00M	-4.20M	-0.47M
Income from Continuing Operations	-2.60M	-2.37M	-2.50M	-5.46M	-5.53M	-7.54M	-8.43M	-9.03M	-12.38M	-14.39M	-14.56M	-17.23M	-16.67M	-18.33M	-21.74M	-22.89M		-27.78M	-26.07M	-33.63M	-42.33M	-41.95M	-45.65M	-45.94M	-50.89M	-56.41M	-55.94M	-66.21M	-74.04M	-76.83M	-80.38M	-96.57M	-115.66M	-130.09M
Consolidated Net Income	-2.60M	-2.37M	-2.50M	-5.46M	-5.53M	-7.54M	-8.43M	-9.03M	-12.38M	-14.39M	-14.56M	-17.23M	-16.67M	-18.33M	-21.74M	-22.89M		-27.78M	-26.07M	-33.63M	-42.33M	-41.95M	-45.65M	-45.94M	-50.89M	-56.41M	-55.94M	-66.21M	-74.04M	-76.83M	-80.38M	-96.57M	-115.66M	-130.09M
Income towards Parent Company	-2.60M	-2.37M	-2.50M	-5.46M	-5.53M	-7.54M	-8.43M	-9.03M	-12.38M	-14.39M	-14.56M	-17.23M	-16.67M	-18.33M	-21.74M	-22.89M		-27.78M	-26.07M	-33.63M	-42.33M	-41.95M	-45.65M	-45.94M	-50.89M	-56.41M	-55.94M	-66.21M	-74.04M	-76.83M	-80.38M	-96.57M	-115.66M	-130.09M
Net Income towards Common Stockholders	-2.60M	-2.37M	-2.50M	-5.46M	-5.53M	-7.54M	-8.43M	-9.03M	-12.38M	-14.39M	-14.56M	-17.23M	-16.67M	-18.33M	-21.74M	-22.89M		-27.78M	-26.07M	-33.63M	-42.33M	-41.95M	-45.65M	-45.94M	-50.89M	-56.41M	-55.94M	-66.21M	-74.04M	-76.83M	-80.38M	-96.57M	-115.66M	-130.09M
Additional items
EPS (Basic)	-1.22	-1.67	-1.68	-2.92	-2.41	-0.38	-0.35	-0.37	-0.51	-0.60	-0.60	-0.71	-0.53	-0.56	-0.66	-0.69		-0.73	-0.71	-0.73	-0.81	-0.78	-0.83	-0.85	-0.94	-1.01	-0.88	-0.93	-0.94	-0.96	-0.87	-1.04	-1.23	-1.38
EPS (Weighted Average and Diluted)															-0.71			-0.73	-0.68	-0.73	-0.81	-0.78	-0.83	-0.85	-0.94	-1.01	-0.88	-0.93	-0.94	-0.96	-0.87	-1.04	-1.23	-1.38
Shares Outstanding (Weighted Average)				22.01M	22.01M	24.02M	24.04M	24.10M	24.14M	24.20M	24.22M	24.57M	32.85M	32.88M	32.92M	33.03M	37.59M	38.56M	47.50M	47.78M	53.51M	53.75M	53.81M	53.91M	54.03M	54.69M	66.80M	69.60M	78.86M	80.04M	92.74M	93.05M	93.68M	94.18M
Shares Outstanding (Diluted Average)															30.45M		37.06M	38.31M	38.44M	47.71M	52.52M	53.77M	51.98M	53.91M	54.27M	56.81M	58.07M	72.29M	79.01M	80.09M	80.78M	93.10M	93.79M	94.22M
EBITDA	-2.61M	-2.37M	-2.50M	-5.46M	-5.57M	-7.59M	-8.43M	-8.93M	-12.34M	-14.47M	-14.60M	-17.34M	-16.53M	-18.40M	-21.66M	-22.91M		-27.87M	-26.10M	-36.44M	-43.80M	-43.32M	-43.91M	-44.58M	-50.17M	-56.62M	-58.26M	-67.76M	-74.39M	-74.60M	-81.67M	-95.73M	-116.02M	-129.52M
Interest Expenses	0.00M	0.00M	0.00M
Shares Outstanding			1.55M	2.19M	2.34M	24.04M	24.06M	24.11M	24.20M	24.22M	24.26M	24.59M	32.88M	32.92M	33.00M	33.02M	37.68M	38.62M	47.60M	4.78M	53.72M	53.80M	53.88M	53.99M	54.68M	66.71M	68.17M	78.54M	79.32M	80.84M	92.93M	93.53M	94.13M	94.55M

Research Tools

Crinetics Pharmaceuticals Income Statement (2017-2025) | CRNX

Create an account

Sign In

Reset Password

Get Pro for 60% off